HomeGLAB • CNSX
add
Gemina Laboratories Ltd
Previous close
$0.40
Year range
$0.28 - $1.25
Market cap
30.25M CAD
Avg Volume
1.03K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Revenue | 10.88K | — |
Operating expense | 703.51K | -10.91% |
Net income | -760.83K | 7.80% |
Net profit margin | -6.99K | — |
Earnings per share | — | — |
EBITDA | -690.44K | 11.97% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.97K | 799.34% |
Total assets | 1.19M | -17.57% |
Total liabilities | 5.58M | 52.19% |
Total equity | -4.39M | — |
Shares outstanding | 76.57M | — |
Price to book | -6.58 | — |
Return on assets | -131.98% | — |
Return on capital | 47.36% | — |
Cash Flow
Net change in cash
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Net income | -760.83K | 7.80% |
Cash from operations | 31.20K | 103.88% |
Cash from investing | — | — |
Cash from financing | -16.93K | -102.10% |
Net change in cash | 14.27K | 2,014.22% |
Free cash flow | 318.50K | 156.01% |
About
Founded
2017
Headquarters
Website
Employees
6
